González-Rodriguez, Maria A.
Troutman, Scott
Bayle, Simon
Lester, Daniel K.
Grove, Matthew
Duckett, Derek
Kareta, Michael S. http://orcid.org/0000-0002-6980-9065
Kissil, Joseph L. http://orcid.org/0000-0002-6471-346X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS117926)
Article History
Received: 15 May 2024
Revised: 14 August 2024
Accepted: 22 August 2024
First Online: 29 August 2024
Competing interests
: The authors declare no conflict of interest exists. JLK serves as a member of the Scientific Advisory Board for Mulberry Therapeutics.
: The authors declare that all methods were performed in accordance with all relevant guidelines and regulations. All animal experiments complied with NIH guidelines and were approved by the Moffitt Cancer Center IACUC under protocol IS00008425. As this study did not include any patient material there was no need for informed consent.